| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.47 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |